Pharmaceutical company in
Lucerne

Organon Central East GmbH

Since 1991 · 11–20 empl.·4.3(10)

Organon Central East GmbH is a pharmaceutical company that develops, registers and markets medicines and health solutions, with a focus on women’s health, biosimilars and established products.

Organon International Services GmbH

Since 2020 · 21–50 empl.·4.3(10)

Organon International Services GmbH is a pharmaceutical company focused on women’s health, biosimilars and established medicines. Its product portfolio includes therapies for reproductive health and contraception as well as treatments in areas such as cardiovascular disease, respiratory conditions, dermatology and breast cancer.

Organon KSA GmbH

Since 2020 · 11–20 empl.·4.3(10)

Organon KSA GmbH is a pharmaceutical company that markets medicines focused on women’s health, as well as biosimilars and established products. Its portfolio includes products for reproductive medicine, contraception, cardiovascular disease, breast cancer, allergies and respiratory conditions available in Switzerland.

MSD Merck Sharp & Dohme AG

Since 1963 · 11–20 empl.·3.9(7)

MSD Merck Sharp & Dohme AG is a biopharmaceutical company engaged in research and development of medicines and vaccines. Its activities in Switzerland include clinical research and the development and production of biotechnological active substances and medicines for clinical trials.

Merck Sharp & Dohme (Switzerland) GmbH

Since 2008 · 1–10 empl.

Merck Sharp & Dohme (Switzerland) GmbH is a research-driven biopharmaceutical company that develops, manufactures and distributes medicines and vaccines. The company focuses on therapeutic areas including oncology, infectious diseases and cardio-metabolic disorders, and coordinates clinical trials and local services in Switzerland.

HAB Invest AG

Since 2009 · 11–20 empl.

The core activity of HAB Invest AG is the development, manufacture and distribution of medical products and pharmaceuticals.

MSD International GmbH

Since 2010 · 1–10 empl.

MSD International GmbH focuses on scientific research and on the development and supply of medicines and vaccines, and conducts clinical research.

AESKULAP International AG

Since 2010 · 11–20 empl.

The core activity of Aeskulap-International includes research and development, medical education, and the manufacture of high-quality medical products and dietary supplements, particularly in the field of cancer treatment and prevention. This also includes medical consulting services, medical tourism, and the production of products for organ therapy and stem cell transplantation.

Dermavant Sciences GmbH

Since 2016 · 21–50 empl.

The core activity of Dermavant Sciences is the development and marketing of innovative therapeutics in immuno-dermatology, particularly for the treatment of skin diseases such as psoriasis, atopic dermatitis, vitiligo and hyperhidrosis.

MSD International Business GmbH

Since 2018 · 21–50 empl.

MSD International Business GmbH is a pharmaceutical company that conducts scientific research, discovers and develops medicines and vaccines, and undertakes clinical trials. It also provides information portals for patients and healthcare professionals and carries out activities related to supply management and animal health.

Organon International GmbH

Since 2020 · 21–50 empl.·4.3(10)

Organon International GmbH is a pharmaceutical company that provides medicines and health solutions focusing on women’s health, biosimilars and established therapies. The company markets medicines across areas such as reproductive medicine, contraception, cardiovascular disease, breast cancer, allergies and asthma and offers product information and an online product overview.

Organon Pensionskasse Schweiz

Since 2021 · 1–10 empl.

Organon Pensionskasse Schweiz is a healthcare company focused on women’s health and general medicines. It develops and markets medicines and products in areas such as reproductive health, contraception, cardiovascular disease, dermatology, allergies and asthma.